Skip to content

Clinical trials

Phase 2 Epilepsy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 2 Country / region: United States Clear all

101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20023
20032
20042
20056
20064
20074
20083
20098
20103
20118
20121
20132
20146
20154
20162
20175
201814
20194
20213
20227
20231
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Terminated16
Unknown status5
Withdrawn3
Recruiting3
Active, not recruiting3
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Inc.7
National Institute of Neurological Disorders and Stroke (NINDS)6
UCB Pharma6
Marinus Pharmaceuticals5
GlaxoSmithKline4
UCB BIOSCIENCES, Inc.4
Acorda Therapeutics3
Jazz Pharmaceuticals3
NeuroPace3
Neurocrine Biosciences3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy101
Seizures43
Epilepsies, Partial12
Drug Resistant Epilepsy6
Epilepsies, Myoclonic4
Lennox Gastaut Syndrome4
Migraine Disorders4
Tuberous Sclerosis4
Autistic Disorder3
Brain Injuries, Traumatic3

Trials

Showing 1 to 25 of 101. Each trial links to its page on Pharma Observatory.

1 more trial matches. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.